Marc Stapley
Chief Executive Officer, Director, Veracyte, Inc.; Director, Glaukos
Bought, 12 months
$0.0M
Sold, 12 months
$10.8M
Companies
2
Latest trade
Jun 4, 2026
Companies
Veracyte, Inc.Chief Executive Officer, Director −$8.9M GlaukosDirector −$1.9MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

